ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/31/2024
Back to search
Official data from USPTO
SIGNAL-LI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SIGNAL-LI
ST13
US500000097060665Class
5, 9, 10, 42, 44
Filing
97060665
Registration
6910671
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
01/31/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
10/05/2021
Registration date
11/29/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2022
Last transaction
11/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
SEVILLE, ES
Examiner
MARTIN, JENNIFER MCGARRY
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
UNIVERSAL DIAGNOSTICS, S.A.
Universal Diagnostics, S.L.
Representatives
Jeffrey H. Handelsman GREENBLUM & BERNSTEIN, P.L.C.
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, namely, cancer and pre-cancer stages
Class 9
Downloadable computer software, namely, software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment; recorded computer software, namely, software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment
Class 10
Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment
Class 42
Providing temporary use of non-downloadable software for the tracking of patient samples, from collection, shipment, storage, reception, preparation, and analysis, to test result, for use with metabolic testing in the field of cancer and pre-cancer stages; providing temporary use of non-downloadable software for the tracking of patient samples, from collection, shipment, storage, reception, preparation, and analysis, to test result, for use with medical testing in the field of cancer and pre-cancer stages; providing temporary use of non-downloadable software for use as a quality control system for metabolic testing in the field of cancer and pre-cancer stages; providing temporary use of non-downloadable software for use as a quality control system for medical testing in the field of cancer and pre-cancer stages; quality control services for others in the field of cancer and pre-cancer stages; metabolic testing quality control services; medical testing quality control services in the field of cancer and pre-cancer stages; providing online non downloadable software to control and improve the reliability and quality of metabolic testing in the field of cancer and pre-cancer stages; providing online non-downloadable software to control and improve the reliability and quality of medical testing in the field of cancer and pre-cancer stages; software as a service (SAAS) services featuring software for analyzing and reporting metabolic testing data in the field of cancer and pre-cancer stages; software as a service (SAAS) services featuring software for analyzing and reporting medical testing data in the field of cancer and pre-cancer stages; providing online non-downloadable computer software, namely, software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment
Class 44
Medical diagnostic testing, monitoring and reporting services in the field of cancer and pre-cancer stages; providing medical advisory, information and consulting services in the field of metabolic testing, namely, in the field of cancer and pre-cancer stages; providing medical advisory, information and consulting services in the field of medical testing, namely, in the field of cancer and pre-cancer stages
Publications
History of USPTO decisions and trademark events.
17 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/29/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/29/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/13/2022
PUBO
PUBLISHED FOR OPPOSITION
09/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/24/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2022
ALIE
ASSIGNED TO LIE
08/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/15/2022
GNRT
NON-FINAL ACTION E-MAILED
02/15/2022
CNRT
NON-FINAL ACTION WRITTEN
02/15/2022
DOCK
ASSIGNED TO EXAMINER
02/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/29/2021
NWAP
NEW APPLICATION ENTERED
10/08/2021
Continuous trademark protection
Get notified about every new filing that threatens SIGNAL-LI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.